Health ❯ Healthcare ❯ Weight Management

Obesity

Weight Loss Medications GLP-1 for Weight Loss GLP-1 Medications Semaglutide Overweight Weight-Loss Drugs BMI Treatment Effects Weight Stigma Patient Support Medication Post-Treatment Support NHS Programs Treatment Options Nutrition GLP-1 Receptor Agonists Medication for Weight Loss Medications Weight Loss Drugs Treatment Guidelines Therapeutic Benefits Weight Loss Treatments Glucose Monitoring Medication Effects BMI Requirements Weight-loss Medications

Study Finds Small Rise in Smell and Taste Diagnoses Among People on GLP‑1 Diabetes Drugs

Prospective studies are needed to test whether the drugs directly affect chemosensory nerves.

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

FDA Clears Signos’ AI CGM for Weight Management as OTC Service Launches